Therefore, we postulated that in the intrauterine development phase and the postpartum, abnormal differentiation process of BPD, RUNX3 down-regulation may be related to EZH2-mediated H3K27me3 modification. This evidence concerns the gene EZH2 and bronchopulmonary dysplasia.